TR201910287T4 - Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. - Google Patents

Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. Download PDF

Info

Publication number
TR201910287T4
TR201910287T4 TR2019/10287T TR201910287T TR201910287T4 TR 201910287 T4 TR201910287 T4 TR 201910287T4 TR 2019/10287 T TR2019/10287 T TR 2019/10287T TR 201910287 T TR201910287 T TR 201910287T TR 201910287 T4 TR201910287 T4 TR 201910287T4
Authority
TR
Turkey
Prior art keywords
dosage form
pharmaceutical dosage
tetrahydrobiopterin
form containing
aqueous solution
Prior art date
Application number
TR2019/10287T
Other languages
English (en)
Turkish (tr)
Inventor
Widmann Rudolf
Bernkop-Schnuerch Andreas
Original Assignee
Orpha Swiss Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orpha Swiss Gmbh filed Critical Orpha Swiss Gmbh
Publication of TR201910287T4 publication Critical patent/TR201910287T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR2019/10287T 2008-08-12 2009-08-07 Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli. TR201910287T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT12542008 2008-08-12

Publications (1)

Publication Number Publication Date
TR201910287T4 true TR201910287T4 (tr) 2019-07-22

Family

ID=41111155

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/10287T TR201910287T4 (tr) 2008-08-12 2009-08-07 Tetrahidrobiopterin ihtiva eden farmasötik dozaj şekli.

Country Status (8)

Country Link
US (1) US20110144117A1 (enExample)
EP (1) EP2309983B1 (enExample)
JP (1) JP2011530540A (enExample)
ES (1) ES2736730T3 (enExample)
PL (1) PL2309983T3 (enExample)
RU (1) RU2011109210A (enExample)
TR (1) TR201910287T4 (enExample)
WO (1) WO2010017570A2 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140108281A (ko) * 2013-01-10 2014-09-05 뉴트리셔널 테라퓨틱스, 인크. 건강 유지 및 급성 및 만성 장애의 치료를 위한 지질 보조제를 함유하는 츄어블 웨이퍼
ES2586945T3 (es) * 2014-03-31 2016-10-19 Vasopharm Gmbh Composiciones farmacéuticas sólidas que comprenden derivados de biopterina y usos de dichas composiciones
CN110312721A (zh) 2016-11-29 2019-10-08 显莎制药公司 墨蝶呤的多晶型物
WO2018102315A1 (en) * 2016-11-29 2018-06-07 Censa Pharmaceuticals Inc. Polymoprhs of sepiapterin and salts thereof
MX2020002271A (es) * 2017-09-01 2020-10-05 Ptc Therapeutics Mp Inc Composiciones farmaceuticas que comprenden sepiapterina y sus usos de las mismas.
CA3102105A1 (en) 2018-05-30 2019-12-05 Ptc Therapeutics Mp, Inc. Compositions and methods for increasing tetrahydrobiopterin plasma exposure
JP7778477B2 (ja) 2018-05-30 2025-12-02 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリンの薬学的に許容される塩
JP7502197B2 (ja) 2018-05-30 2024-06-18 ピーティーシー セラピューティクス エムピー，インコーポレイテッド セピアプテリン血漿曝露を増加させるための方法
JP7553906B2 (ja) * 2018-11-01 2024-09-19 宏 一瀬 Ｓｐｒをコードするポリヌクレオチドを含む組換えベクター、及びそれを含む組成物
LT4009978T (lt) 2019-08-05 2024-11-25 Ptc Therapeutics Mp, Inc. Sepiapterino ir jo metabolitų panaudojimas spinduliuotės poveikio gydymui

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61277618A (ja) * 1985-06-04 1986-12-08 Suntory Ltd 自閉症治療剤
JP2588191B2 (ja) * 1987-04-24 1997-03-05 サントリー株式会社 悪性腫瘍および重症ウイルス感染症に伴う神経症状を改善するための治療剤
DE10260263A1 (de) * 2002-12-20 2004-07-15 Biocrates Life Sciences Gmbh Verwendung von Tetrahydrobiopterinderivaten zur Behandlung und Ernährung von Patienten mit Aminosäurestoffwechselstörungen
US20080207624A1 (en) * 2004-05-11 2008-08-28 Osamu Sugita Therapeutic Agent for Bh4-Responsive Hyperphenylalaninemia
CN101132776A (zh) * 2004-11-17 2008-02-27 生物马林药物股份有限公司 稳定的四氢生物喋呤片剂制剂
US20060188492A1 (en) * 2005-01-13 2006-08-24 Chronorx Llc, An Alaska Limited Liability Company Topical management of ocular and periocular conditions
JP2008540486A (ja) * 2005-05-11 2008-11-20 ニコメッド ゲゼルシャフト ミット ベシュレンクテル ハフツング Ｐｄｅ４インヒビター及びテトラヒドロビオプテリン誘導体との組合せ物
KR20160065998A (ko) * 2007-04-11 2016-06-09 바이오마린 파머수티컬 인크. 테트라하이드로바이오프테린 투여 방법, 관련 조성물 및 측정 방법

Also Published As

Publication number Publication date
US20110144117A1 (en) 2011-06-16
EP2309983B1 (de) 2019-04-24
ES2736730T3 (es) 2020-01-07
RU2011109210A (ru) 2012-09-20
WO2010017570A3 (de) 2010-08-05
PL2309983T3 (pl) 2019-09-30
JP2011530540A (ja) 2011-12-22
WO2010017570A2 (de) 2010-02-18
EP2309983A2 (de) 2011-04-20

Similar Documents

Publication Publication Date Title
WO2010017570A3 (de) Pharmazeutische darreichungsform enthaltend tetrahydrobiopterin
CR20110278A (es) Cartucho, un dispensador de medicamentos para porciones de medicamentos sólidos y el uso del cartucho y del dispensador de medicamentos
MY150638A (en) Oral care implement having reservoir for dispensing active agent
EA201290833A1 (ru) Применение амисульприда в качестве противорвотного средства
TN2012000371A1 (en) Pyrazole compounds as crth2 antagonists
MX341433B (es) Composicion antitranspirante/desodorante anhidra liquida.
WO2014102613A3 (en) Device for disposal and neutralization of pharmaceutical agents
MX2020011961A (es) Formas de dosis de liberacion controlada para substancias de farmaco de alta dosis, solubles en agua e higroscopicas.
PL1998762T3 (pl) Stałe postacie dawkowania zawierające składnik czynny o zamaskowanym smaku
MX2010005385A (es) Medicamentos topicos para la terapia antimicotica.
MX2010009759A (es) Dispositivo dosificador.
UA103025C2 (ru) Твердая композиция лекарственного средства замедленного высвобождения
IL206492A (en) The heterocyclic spherical cycles and compounds for use as drugs selectively with additional active substance
AR063709A1 (es) Diposicion de dosificacion de cafe y te
EA201400737A1 (ru) Система доставки на основе множества пеллет с немедленным высвобождением активного вещества
WO2010131887A2 (ko) 탈모 방지 또는 육모 촉진을 위한 조성물
CO6592109A2 (es) Nueva forma cristalina de un derivado de ciclopropilbenzamida
MY163012A (en) Pyrazole compounds as crth2 antagonists
MA32831B1 (fr) Distributeur de medicament et son utilisation
TR200806300A2 (tr) Çözünürlük artırıcı farmasötlk formulasyon
CO6700853A2 (es) Formulación granular estable durante el almacenamiento y proceso para la formulacíón del mismo
IT1400708B1 (it) Dispositivo per la ricostituzione dosata e la somministrazione di soluzioni liquide contenenti sostanze attive disponibili in forma separata, in particolare in polvere o gel.
PH12015500374A1 (en) Extended release compositions of an aminoalkyl nitrate
EA201590732A1 (ru) Диспергируемая таблетка
EA201301021A1 (ru) Применение пригодной для распыления композиции, содержащей амброксол